1012 related articles for article (PubMed ID: 17107431)
1. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R
J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431
[TBL] [Abstract][Full Text] [Related]
2. Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
Gallien S; Taieb F; Schlemmer F; Lagrange-Xelot M; Atlan A; Sarfati C; Molina JM
Travel Med Infect Dis; 2008 May; 6(3):128-9. PubMed ID: 18486067
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
5. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
Mavrogordato A; Lever AM
J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
7. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
[TBL] [Abstract][Full Text] [Related]
8. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
[TBL] [Abstract][Full Text] [Related]
9. Problems in the therapy for imported malaria in the United States.
Singh K; Wester WC; Trenholme GM
Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
11. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
Patel SN; Kain KC
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
[TBL] [Abstract][Full Text] [Related]
14. Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic.
Maguire JD; Llewellyn DM
J Travel Med; 2007; 14(6):411-4. PubMed ID: 17995538
[TBL] [Abstract][Full Text] [Related]
15. Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report.
Blossom DB; King CH; Armitage KB
Am J Trop Med Hyg; 2005 Jul; 73(1):188-90. PubMed ID: 16014856
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
[TBL] [Abstract][Full Text] [Related]
17. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
[TBL] [Abstract][Full Text] [Related]
18. Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
Le Goff M; Kendjo E; Thellier M; Piarroux R; Boelle PY; Jauréguiberry S;
Clin Infect Dis; 2023 Feb; 76(3):e884-e893. PubMed ID: 35962785
[TBL] [Abstract][Full Text] [Related]
19. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
van Genderen PJ; Koene HR; Spong K; Overbosch D
J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
[TBL] [Abstract][Full Text] [Related]
20. Malaria prevention in travelers.
Juckett G
Am Fam Physician; 1999 May; 59(9):2523-30, 2535-6. PubMed ID: 10323359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
